Journal article
Topiramate treatment for SSRI-induced weight gain in anxiety disorders.
Abstract
BACKGROUND: Antidepressants, including selective serotonin reuptake inhibitors (SSRIs), have been associated with significant weight gain, a problem that frequently leads to noncompliance and premature discontinuation of treatment. Topiramate is a novel anticonvulsant that has also been used as a mood stabilizer and augmentation agent in mood disorders. Topiramate has been observed to have an interesting side effect of weight loss in some …
Authors
Van Ameringen M; Mancini C; Pipe B; Campbell M; Oakman J
Journal
The Journal of Clinical Psychiatry, Vol. 63, No. 11, pp. 981–984
Publisher
Physicians Postgraduate Press
Publication Date
November 15, 2002
DOI
10.4088/jcp.v63n1104
ISSN
0160-6689